Quantcast

Sheppard Mullin Advises Arcus Health Services, The Benchmark Company, Gateway Fleets, LendLease and Others in Recent Deals

LEGAL NEWSLINE

Thursday, November 28, 2024

Sheppard Mullin Advises Arcus Health Services, The Benchmark Company, Gateway Fleets, LendLease and Others in Recent Deals

Law1

Law Firm | Unplash by Tingey Injury Law Firm

Sheppard Mullin’s Corporate practice has closed several transactions recently:

Mergers & Acquisitions

Represented home health agency Arcus Health Services in a series of acquisitions of privately held businesses that provide in-home personal care services to patients: Georgia-based Vera Loving Care, LLC; Courageous Home HealthCare Inc.; Courageous Inc.; and South Carolina-based Guardian Angel Senior Care LLC. The deal was led by partner Stephanie Marcantonio, associate Alexandria Foster and law clerk Jessica Missel.

Represented LendLease, a global real estate group headquartered in Sydney, Australia, in the carveout sale of its New York and New Jersey construction operations, including a portfolio of construction projects valued at over $1.8 billion, to Consigli Building Group, Inc., one of the largest employee-owned construction managers in the Northeast and Mid-Atlantic. The deal was led by associate Patrick Quine and partner Shon Glusky.

Represented VineLight Ventures in its acquisition of SitusAMC’s loan insurance entity, Securent Risk Retention Group Inc., and its related data, brokerage and services business, Securent Risk and Insurance Services, LLC. The deal was led by partner Shon Glusky, special counsel Matthew Silverstein and associates Zana Operta and Brett Uslaner.

Private Equity

Represented San Francisco-based Gateway Fleets in its investment by Swiss-based private equity firm Partners Group. Gateway Fleets provides a solution-as-a-service model for equipment and services to enable logistics fleet operators to transition to electric vehicles. The deal was led by partners Shon Glusky, Dmitriy Chelnitsky and Tony Toranto and special counsel Matthew Silverstein.

Public Offerings

Represented The Benchmark Company as Underwriter in connection with Innovation Beverage Group Limited’s $5.45 million initial public offering of Common Stock. The deal was led by partner Richard Friedman and associates Nazia Khan, Emily Mastoloni and Hannah Zelcer.

Advised Ladenburg Thalmann & Co, Inc. as Placement Agent in connection with Calidi Biotherapeutics, Inc.’s $2.1 million Warrant Exercise. San Diego-based Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage immuno-oncology company with proprietary technology designed to arm the immune system to fight cancer. The deal was led by partners Richard Friedman and Stephen Cohen.

Represented Legacy Education, a for-profit, post-secondary education company, in its $11.5 million initial public offering. Legacy Education offers a wide range of education programs and services to help students achieve their professional goals. They intend to use the proceeds for investments at their facilities and for the development of new programs. The deal was led by partners Richard Friedman and Stephen Cohen and associates Emily Mastoloni and Hannah Zelcer.

Represented Nova Minerals Limited (Nasdaq NVA, NVAWW) (ASX: NVA), (OTC: NVAAF) (FSE: QM3), a gold and critical minerals exploration stage company focused on advancing the Estelle Gold Project in Alaska, in connection with two public offerings. The first, a $3.287 million public offering in the U.S. and listing on Nasdaq. The second, a $2.3 million public offering aimed at bolstering resource and exploration field programs. The deals were led by partner Jeffrey Fessler, special counsel Greg Carney and associate Ashton Wiebe.

Advised Syra Health Corp., a healthcare technology company powering better health by providing meaningful solutions, in its $2.1 million public offering of Class A Common Stock and Series A and B Warrants. The deal was led by partner Jeffrey Fessler and associates Nazia Khan and Hannah Zelcer.

Represented ThinkEquity as Underwriter in BioVie Inc.’s $3 million public offering of its Common Stock, pre-funded Warrants and Warrants. BioVie is a clinical-stage life sciences company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders. The deal was led by partners Jeffrey Fessler, Richard Friedman and Stephen Cohen.

Advised WallachBeth, Inc. as underwriter in connection with KindlyMD, Inc.’s $6.8 million initial public offering of Common Stock and Warrants. KindlyMD is a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies to offer patients comprehensive care and reduce the addiction and dependency of opioid use in the U.S. The deal was led by partners Richard Friedman and Stephen Cohen and associate Emily Mastoloni.

Original source can be found here.

ORGANIZATIONS IN THIS STORY

More News